期刊文献+

紫杉醇对大鼠平滑肌细胞凋亡的影响 被引量:1

The Study on the Relationship Between Paclitaxel and Apoptosis of VSMC
下载PDF
导出
摘要 目的观察术后抗再狭窄药物紫杉醇对平滑肌细胞凋亡的影响及量效、时效关系。方法培养大鼠主动脉平滑肌细胞,培养至4到9代。根据紫杉醇作用时间不同将细胞分成24小时组和72小时组,每一时间组根据加入不同浓度紫杉醇分四组:0μmol/L,0.1μmol/L,1μmol/L,10μmol/L组。用流式细胞仪检测紫杉醇是否引起细胞凋亡,并观察此作用与药物浓度和时间的关系。结果紫杉醇作用VSMC24小时后0μmol/L组及低、中、高浓度紫杉醇组细胞凋亡率分别为2.2%、3.6%、6.8%、22.6%;72小时后细胞凋亡率分别为6.1%、10.4%、15.4%、42.7%。结论紫杉醇能促进平滑肌细胞的凋亡,随着药物浓度提高,作用时间延长,细胞凋亡率也相应升高。故促进平滑肌细胞调亡可能是紫杉醇抑制平滑肌细胞过度增殖的重要机制。 Objective Percutaneous transluminal coronary angioplasty (PTCA) is limited by restenosis. The effect of paclitaxel, which can prevent restenosis,on the VSMC apoptosis ,and the relation between result ,time and dosage were observed. Methods The VSMC were devided into two groups, the 24 hours group and 72 hours group.And there are four different dosage groups in every time group:0 μmol/L, 0.1 μmol/L,1 μmol/L and 10 μmol/L.The flow cytometer was used to observe the relation between result, time and dosage. Result That experiment has demonstrated that :the apoptosis rate of 0 μmol/L group, low, medium and high concentration paclitaxel group were 2.2%,3.6%,6.8% and 22.6% after 24 hours,6.1%,10.4%,15.4% and 42.7% after 72 hours. Conclusion Paclitaxel can induce cell apoptosis, and the higher dosage the longer the time,the higher apoptosis ratio accordingly. Accelerating cell apoptosis is the principal mechanism of paclitaxel preventing the SMC over proliferation.
出处 《南华大学学报(医学版)》 2005年第3期344-346,387,共4页 Journal of Nanhua University(Medical Edition)
关键词 紫杉醇 平滑肌细胞 调亡 paclitaxel VSMC apoptosis
  • 相关文献

参考文献6

  • 1Dorothea I,Axel,Wolfgang Kunert.Paclitaxel inhibits arterial smooth muscle cell proliferation and migration in vitro and in vivo using local durg delivery[J].Circulation,1997,96:636—645.
  • 2Eberhard Grube.TAXUS I:six and twelvemonth result from a randomized,double-blind trial on a slow—release paclitxel-eluting stent for denovo coronary lesions[J].Circulation,2003,107:38—42.
  • 3Kengo Tanabe.Chronic arterial responses to polymer-controlled paclitaxel-eluting stents by serisl intravascular ultrasound analysis:data from the randomized TAXUS—Ⅱ trial[J].Circulation,2004,109:196—200.
  • 4Kengo Tanabe.TAXUS Ⅲ trial:in-sten restenosis treated with stent-based delivery of paclitaxel in-corporated in a slow-release polymet formation[J].Circulation,2003,107:559—564.
  • 5Gregg W Stone.One—year clinical resuhs with the slow-release polymer-based paclitaxeleluting TAXUS stent:the TAXUS—Ⅳ trial[J].Circulation,2004,109:1942—1947.
  • 6Tzu—Hao Wang.Microtubule dystun—ction induced by paclitaxel initiates apoptosis through both c-jun N-terminal Kinase(JNK)-dependent and-independent pathways in ovarian cancer cells[J].J Biol Chem,1999,274(12):8208—8216.

同被引文献8

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部